目的：探讨选择性动脉栓塞疗法治疗盆腔恶性肿瘤急性大出血的临床价值。
Methods Sixteen patients with acute hemorrhea of pelvic malignant tumor were underwent with selective artery embolism, whose therapeutic effect and complication were observed.
对此类病变的处置方式包括观察、栓塞疗法、硬化疗法、外科减压或固定和放疗等一系列措施。
The management options for these lesions include a combination of observation, embolization, sclerotherapy, surgical decompression, or stabilization and radiotherapy.
结论：AKBR是直接反映肝损伤肝活力程度的一个量化指标，对判断肝脏对栓塞疗法的耐受程度及术后并发症的发生具有重要临床价值。
Conclusion: AKBR which reflects hepatic mitochondrial REDOX state is more reliable as direct indicator to assess hepatic tolerance for embolization therapy than routine liver function test.
雌激素替代疗法是传统的治疗，但是因为与中风，栓塞，乳腺癌之间的风险联系医生已经不推荐长期使用雌激素进行治疗。
Estrogen hormone replacement therapy was the traditional treatment, but it is no longer recommended for the long term because of links to stroke, embolism and breast cancer.
肝癌的治疗选择包括化疗、栓塞、消融和质子束疗法。
Treatment options for HCC include chemotherapy, chemoembolization, ablation and proton-beam therapy.
如果可能，在进行可能会增加血管栓塞风险或将会长期不活动的手术之前，雌激素疗法应该停止4到6周。
If possible, estrogen therapy should be discontinued at least 4 to 6 weeks before any surgery associated with an increased risk for thromboembolism or during periods of prolonged immobilization.
目的探讨动脉化疗栓塞联合放射疗法治疗晚期贲门癌的疗效。
Objective To investigate the treatment effects of transarterial chemoembolization(TACE) combined with radiotherapy on advanced cardiac carcinoma.
急性肺栓塞使肺动脉压力及肺血管阻力明显升高，溶栓疗法使肺动脉压力及肺血管阻力明显降低，对照组两参数在栓塞后随时间无明显变化。
Pulmonary artery pressure and pulmonary resistance increased markedly after pulmonary embolism, which were lowered progressively and significant by thrombolytic therapy in contrary with control dogs.
结论经肝动脉栓塞化疗是治疗肝转移癌的一种有效疗法，不良反应可耐受。
ConclusionThe TACE in the treatment of the metastatic liver cancer is effective and tolerable.
结论经肝动脉栓塞化疗是治疗肝转移癌的一种有效疗法，不良反应可耐受。
ConclusionThe TACE in the treatment of the metastatic liver cancer is effective and tolerable.
应用推荐